Pavion Blue Capital’s Eli Lilly LLY Stock Holding History

Pavion Blue Capital’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.16M	Hold	1,805	–	–	0.87%	34
2026 Q1	$1.66M	Hold	1,805	–	–	0.72%	37
2025 Q4	$1.94M	Buy	1,805 +5	+0.3%	+$4.78K	0.81%	33
2025 Q3	$1.37M	Hold	1,800	–	–	0.59%	38
2025 Q2	$1.4M	Hold	1,800	–	–	0.62%	38
2025 Q1	$1.49M	Hold	1,800	–	–	0.71%	38
2024 Q4	$1.39M	Hold	1,800	–	–	0.65%	40
2024 Q3	$1.59M	Sell	1,800 -1,143	-39%	-$1.03M	0.74%	38
2024 Q2	$2.66M	Hold	2,943	–	–	1.31%	25
2024 Q1	$2.29M	Hold	2,943	–	–	1.13%	25
2023 Q4	$1.72M	Hold	2,943	–	–	0.95%	33
2023 Q3	$1.58M	Hold	2,943	–	–	0.96%	33
2023 Q2	$1.38M	Buy	2,943 +100	+4%	+$41.9K	0.8%	35
2023 Q1	$976K	Hold	2,843	–	–	0.6%	44
2022 Q4	$1.04M	Hold	2,843	–	–	0.66%	42
2022 Q3	$919K	Hold	2,843	–	–	0.66%	42
2022 Q2	$922K	Hold	2,843	–	–	0.62%	42
2022 Q1	$814K	Buy	2,843 +700	+33%	+$180K	0.48%	49
2021 Q4	$592K	Hold	2,143	–	–	0.34%	55
2021 Q3	$495K	Hold	2,143	–	–	0.31%	56
2021 Q2	$492K	Buy	2,143 +443	+26%	+$89K	0.3%	57
2021 Q1	$318K	Hold	1,700	–	–	0.21%	64
2020 Q4	$287K	Hold	1,700	–	–	0.2%	67
2020 Q3	$252K	Hold	1,700	–	–	0.19%	70
2020 Q2	$279K	Hold	1,700	–	–	0.24%	63
2020 Q1	$236K	Hold	1,700	–	–	0.24%	63
2019 Q4	$223K	Buy	+1,700	New	+$197K	0.22%	56

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Pavion Blue Capital's LLY Position: Q2 2026 in Review

Pavion Blue Capital held its Eli Lilly (LLY) position steady in Q2 2026 at 1,805 shares worth $2.16M. The position accounts for 0.87% of the portfolio, ranked #34.

Pavion Blue Capital first reported a position in LLY in Q4 2019 and has held it in 27 quarters since. The position peaked at $2.66M in Q2 2024. 4,633 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

Pavion Blue Capital held 1,805 shares of Eli Lilly worth $2.16M as of Q2 2026.
Pavion Blue Capital left its Eli Lilly share count unchanged in Q2 2026.
Eli Lilly made up 0.87% of Pavion Blue Capital's portfolio in Q2 2026, its #34 holding.
Pavion Blue Capital first reported a position in Eli Lilly in Q4 2019 and has held it in 27 quarters since.
Pavion Blue Capital's Eli Lilly position peaked at $2.66M in Q2 2024.
4,633 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Pavion Blue Capital's 13F filing for Q2 2026, filed 7 Aug 2026.